ICD-10-CM › Z00-Z99 › Z17 › Z17 Estrogen, and other hormones and... › Z17.1
Estrogen receptor negative status [ER-]
ValidICD-10-CM diagnosis code.
Valid for claims with a date of service in the current code year.
What has happened to this code
Every change the publisher made, from 2007 to now. Entries marked draft are from the pre-implementation releases: ICD-10 took effect on 1 October 2015, so nothing before FY2016 was ever valid on a claim.
- FY2007 Added to the draft code set draft Estrogen receptor negative status [ER-]
Official coding rules
Published by CDC for FY2027. A rule attached to a category binds every code beneath it, so the rules inherited from this code's ancestors are shown with the code they come from.
Inherited from Z17 Estrogen, and other hormones and factors receptor status
Code first
- malignant neoplasm, such as:
- malignant neoplasm of breast (C50.-)
- malignant neoplasm of ovary (C56.-)
Note
- Use one code, as available, for each receptor: Z17.0, Z17.1, Z17.2-, Z17.3-
How CDC's index refers to this code
Wording from the official alphabetic index. Much of it appears nowhere in the code description, which is why a search for the everyday phrase so often finds nothing.
- Postsurgery status
- Status > estrogen receptor > negative
Codes in the same group
| Code | Description | Status |
|---|---|---|
| Z17.0 | Estrogen receptor positive status [ER+] | Valid |
| Z17.2 | Progesterone receptor status | Not billable |
| Z17.3 | Human epidermal growth factor 2 receptor | Not billable |
| Z17.4 | Combined receptor status | Not billable |